The Swedish Drug Delivery Center (SweDeliver)

Purpose and goal

The Swedish Drug Delivery Center (SweDeliver) is a competence center which consolidates world-class, needs-driven drug delivery science of benefit for pharmaceutical innovation in Sweden. The center will develop a strong research portfolio to position the region as world leading in drug delivery science. We will build an ecosystem maintaining scientific and industrial know-how in the region. SweDeliver promotes healthy lives and well-being by providing support to development of new innovative products for diseases currently without treatment.

Expected effects and result

Expected impact of SweDeliver include i) Translational results that move novel drug delivery formulations strategies through preclinical in vivo models to clinical studies in healthy volunteers or suitable patient population; ii) Identification of advanced drug delivery systems that enable product development of challenging drug molecules; iii) Increased collaboration and mobility of academic and industrial partners, important for the success of the science and training programs; and iv) Increased attractiveness for international recruitment to and investment in Sweden.

Planned approach and implementation

SweDeliver has four work packages (WPs); WP1-3 are research-centered and dedicated to different drug delivery routes (parenteral, oral, pulmonary) whereas WP4 is focused on training and career development. WP4 activities are performed across WP1-3 with emphasize on training related to emerging molecules and techniques (biological drugs/new modalities, computational modelling, high-resolution analytics e.g. scattering and imaging techniques), as well as soft skills. SweDeliver is governed by an industrial-academic board, and has implemented a clear reporting structure.